Last year, the Children’s Tumor Foundation announced Synodos for NF1, a unique consortium bringing together a multidisciplinary team of scientists, clinicians, technicians, patients and other experts from world-class labs at academic and medical centers. These scientists have pledged to work together and share unpublished information, datasets, and results, thereby accelerating the drug development process.
Three separate consortia make up Synodos for NF1. One of these groups of researchers, from the University of Minnesota, explain the work being done:
To learn more, visit ctf.org/synodos.
